Cerebellar TMS and Satiety in Prader-Willi Syndrome
Part of paid clinical trials in Belmont, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT05938543
- Status
- Recruiting
Conditions
- Prader-Willi Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 64 Years
- Healthy Volunteers
- Not accepted
Interventions
- Repetitive Transcranial Magnetic Stimulation (rTMS) — DEVICErTMS is a technique of TMS that allows for selective external manipulation of neural activity in a non-invasive manner. During rTMS a rapidly changing current is passed through an insulated coil placed against the scalp. This generates a temporary magnetic field, which in turn induces an electrical current in neurons and allows for modulation of neural circuitry. Other Name: iTBS
Study Details
This study uses a noninvasive technique called transcranial magnetic stimulation (TMS) to study hyperphagia and satiety in Prader-Willi syndrome. TMS is a noninvasive way of stimulating the brain, using a magnetic field to change activity in the brain. The magnetic field is produced by a coil that is held next to the scalp. In this study, the investigators will be stimulating the brain to learn more about how TMS might improve hyperphagia in Prader-Willi syndrome.
Key Dates
- Start date
- Sep 1, 2023
- Status verified
- Dec 2025
- Primary completion
- Sep 30, 2026
- Completion
- Oct 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- BASIC_SCIENCE
Arms
- Experimental: Active cerebellum rTMSCerebellar targeted iTBS, once daily, one week
Primary Outcome Measure
Retention of subjects in study assessments [ Time Frame: 1-week post-TMS follow-up visit ]
Central Contacts
- Laura Holsen, PhD617-525-8772
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| McLean Hospital | Belmont | Massachusetts | 02478 | Mark Halko, PhD |
Find similar trials in Belmont, MA
By research site
Related Studies
- A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway ImpairmentPHASE1/PHASE2 · Recruiting · Rhythm Pharmaceuticals, Inc. · Birmingham, Alabama
- Early Check: Expanded Screening in NewbornsEnrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Parent and Infant Inter(X)Action Intervention (PIXI)Enrolling By Invitation · RTI International · Research Triangle Park, North Carolina
- Impact of Bright Light Therapy on Prader-Willi SyndromeRecruiting · Maimonides Medical Center · Brooklyn, New York